Hernández SJM, Martínez SLM, Doria RAM, Roldán TMD, Bustamante BÁS, Morales QN, Hernández RF, Cárdenas CHJ, Álvarez HLF, Corena GF

Language: Spanish
References: 18
Page: 7-11
PDF size: 226.33 Kb.

ABSTRACT

Introduction. It is estimated that 40% of patients with dengue require medical attention and work incapacity between five and seven days; situation that forces patients to incur out-of-pocket expenses.
Objective. Recognize the out of pocket expenses of patients diagnosed with dengue in Medellin and Monteria.
Materials and Methods. Observational, descriptive, cross-sectional study. 75 patients with dengue were admitted between July 2016 and December 2017, a survey was applied to know the out of pocket expenses that they assumed during the diagnosis and recovery of the disease. To the variables expressed as ratio their mean standard deviation was estimated, and proportions were calculated for the measurements at nominal and ordinal levels.
Results. 75 patients were included, the average age 36.6 years. 74.6% of participants belonged to social status 1, 2 and 3, 56% were in the contributory regime of the Social Security Health System and only 20% required hospitalization. The most frequent expenses were value of the visit, medicines, income not received due to disability and accompaniment, with the unearned income and drugs being the most expenses, with a median of 200 thousand and 25 thousand Colombian pesos, respectively.
Conclusions. Out of pocket expenses incurred by patients can represent between 9 and 45% of their income; which means that for some families, dengue behaves like a catastrophic event. The main costs are hospitalization and work disability.

REFERENCES

1. Hu, T.S., Zhang, H.L., Feng, Y., Fan, J.H., Tang, T., Liu, Y.H. et al., “Epidemiological and molecular characteristics of emergent dengue virus in Yunnan Province near the China-Myanmar-Laos border, 2013-2015”, bmc Infect Dis, 2017, 17 (1) :331.

2. Agha, S.B., Tchouassi, D.P., Bastos, A.D.S. y Sang, R., “Dengue and yellow fever virus vectors: seasonal abundance, diversity and resting preferences in three Kenyancities”, Parasit Vectors, 2017, 10 (1): 628.

3. Udayanga, L., Gunathilaka, N., Iqbal, M.C.M., Pahalagedara, K., Amarasinghe, U.S. y Abeyewickreme, W., “Socioeconomic, knowledge attitude practices (kap), household related and demographic based appearance of nondengue infected individuals in high dengue risk areas of Kandy District, Sri Lanka”, bmc Infect Dis, 2018, 18 (1): 88.

4. Murray, N.E., Quam, M.B. y Wilder-Smith, A., “Epidemiology of dengue: past, present and future prospects”, Clin Epidemiol, 2013, 5: 299-309.

5. International Travel and Health Dengue, World Health Organization (who), Ginebra, 2013, disponible en: http:// www.who.int/ith/diseases/dengue/en/index.html. (Fecha de consulta: 4 de septiembre de 2018).

6. Sabchareon, A., Wallace, D., Sirivichayakul, C., Limkittikul, K., Chanthavanich, P., Suvannadabba, S. et al., “Protective efficacy of the recombinant, live-attenuated, cyd tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial”, Lancet, 2012, 380 (9853): 1559-1567.

7. Messina, J.P., Brady, O.J., Scott, T.W., Zou, C., Pigott, D.M., Duda, K.A. et al., “Global spread of dengue virus types: mapping the 70 year history”, Trends Microbiol, 2014, 22 (3): 138-146.

8. El Fezzazi, H., Branchu, M., Carrasquilla, G., Pitisuttithum, P., Perroud, A.P., Frago, C. et al., “Resource use and costs of dengue: analysis of data from phase iii efficacy studies of a tetravalent dengue vaccine”, Am J Trop Med Hyg 2017, 97 (6): 1898-1903.

9. Shepard, D.S., Undurraga, E.A. y Halasa, Y.A., “Economic and disease burden of dengue in Southeast Asia”, plos Negl Trop Dis, 2013, 7 (2): e2055.

10. Bello, S., Díaz, E., Malagón, J., Romero, M. y Salaza, V., “Medición del impacto económico del dengue en Colombia: una aproximación a los costos médicos directos en el periodo 2000-2010”, Biomédica, 2011, 31 (sup. 3): 3-315.

11. Lee, J.S., Mogasale, V., Lim, J.K., Carabali, M., Lee, K.S., Sirivichayakul, C. et al., “A multi-country study of the economic burden of dengue fever: Vietnam, Thailand, and Colombia”, plos Negl Trop Dis, 2017, 11 (10): e0006037.

12. Stahl, H.C., Butenschoen, V.M., Tran, H.T., Gozzer, E., Skewes, R., Mahendradhata, Y. et al., “Cost of dengue outbreaks: literature review and country case studies”, bmc Public Health, 2013, 13: 1048.

13. Padrón, H., “Relationship of poverty, iniquity and social exclusion with highly costly diseases in Mexico”, Rev Cubana Salud Pública, 2006, 32 (2) disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid =S0864-34662006000200007&.

14. Huy, R., Wichmann, O., Beatty, M., Ngan, C., Duong, S., Margolis, H.S. et al., “Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study”, bmc Public Health, 2009, 9: 155.

15. Xuan, B., Thu, G., Hoang, L., Tuan, A., Thanh, T., Thanh. B. et al., “Cost-of-illness and the health-related quality of life of patients in the dengue fever outbreak in Hanoi in 2017”, B Int J. Environ Res Public Health, 2018, 15: 1174.

16. Castañeda-Orjuela, C., Díaz, H., Alvis-Guzmán, N., Olarte, A., Rodríguez, H., Camargo, G. et al., “Burden of disease and economic impact of dengue and severe dengue in Colombia 2011”, Value Health Reg Issues, 2012, 1 (2): 123-128.

17. Martelli, C.M., Siqueira, J.B. Jr, Parente, M.P., Zara, A.L., Oliveira, C.S., Braga, C. et al., “Economic impact of dengue: multicenter study across four Brazilian regions”, plos Negl Trop Dis, 2015, 9 (9): e0004042.

18. Mia, M.S., Begum, R.A., Er, A.C. y Pereira, J.J., “Assessing the cost burden of dengue. Infection to households in Seremban, Malaysia, Southeast Asian”, J Trop Med Public Health, 2016, 47 (6): 1167-1176.